US Stocks
/
Keros Therapeutics, Inc. Share Price
Keros Therapeutics, Inc. Share Price

Keros Therapeutics, Inc. Share Price

NASDAQ: KROS | Small Cap
$11.64
+$0.42 (3.70%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Keros Therapeutics, Inc. Stock Performance

Open
$11.14
Prev. Close
$11.22
Circuit Range
N/A
Day Range
$11.10 - $11.70
Year Range
$9.73 - $22.47
Volume
6,820
Average Traded
$11.37

Keros Therapeutics, Inc. Share Price Today

As of 9 October 2026, Keros Therapeutics, Inc.'s share price is $11.64. The stock opened at $11.14, compared to its previous close of $11.22. During today's trading session, Keros Therapeutics, Inc.'s share price traded between $11.10 and $11.70, with an average price of $11.40. Over the past 52 weeks, the stock has recorded a high of $22.47 and a low of $9.73. In terms of performance, Keros Therapeutics, Inc.'s share price has risen by 4.77% over the last six months and is down 23.42% on a year-on-year basis.

Keros Therapeutics, Inc. Share Price Chart

$11.10$11.70
L
Show Current Price
H

Keros Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$433.25M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.19
Revenue (TTM)
$244.06B
Return On Equity (TTM)
-31.70%
Profit Margin
35.65%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-294.37%

Keros Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$14.26$0.39$0.37$0.00
Net Profit-$7.28-$23.46-$23.71-$28.71
Net Profit Margin-51.05%-6015.38%-6408.11%N/A
Income ChangeN/A-222.25%-1.07%-21.09%

Keros Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.15$3.55$244.06
Net Profit-$104.68-$152.99-$187.35$87.01
Net Profit MarginN/A-101993.33%-5277.46%35.65%
Income ChangeN/A-46.15%-22.46%146.44%

About Keros Therapeutics, Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Keros Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$11.19
$11.64
+2.33%
Sep 2026
$10.96
$11.38
+1.25%
Aug 2026
$10.18
$11.24
+11.95%
Jul 2026
$10.77
$10.04
-5.86%
Jun 2026
$11.03
$10.66
-5.03%
May 2026
$11.20
$11.23
+1.08%
Apr 2026
$11.49
$11.11
+0.54%
Mar 2026
$13.95
$11.05
-22.21%
Feb 2026
$18.28
$14.21
-20.55%
Jan 2026
$19.57
$17.88
-12.07%
Dec 2025
$17.50
$20.34
+16.20%
Nov 2025
$15.07
$17.50
+15.13%

KROS Share Price FAQs

What is Keros Therapeutics, Inc. share price today?

chevron-up
Keros Therapeutics, Inc. share price today is $11.64 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Keros Therapeutics, Inc. stock?

chevron-up
The 52 week high of Keros Therapeutics, Inc. stock is $22.47, while the 52 week low is $9.73 as of 9 Oct '26.

What is KROS's market capitalisation today?

chevron-up
KROS market capitalisation is $433.25M as of October 9, 2026, at 4:48 pm IST.

What is KROS's net income for the last quarter?

chevron-up
KROS's net income for the last quarter is -28.71B USD.

What is the 5 year returns of KROS?

chevron-up
The 5 year returns of KROS is -72.10% as on 9 Oct '26.

What is the high & low stock price of KROS today?

chevron-up
KROS stock price hit a high of $11.70 and low of $11.10 as of 9 Oct '26.

Can I buy KROS shares in India?

chevron-up
Yes. You can buy KROS in India by opening an international trading account.